ALS
Clinical trials for ALS explained in plain language.
Never miss a new study
Get alerted when new ALS trials appear
Sign up with your email to follow new studies for ALS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race for an oral ALS treatment ends early
Disease control TerminatedThis study aimed to test if an oral version of the drug edaravone could help slow the progression of ALS over 48 weeks. It involved 384 adults recently diagnosed with ALS who showed a specific rate of decline in their physical abilities. The trial was terminated early, so its fin…
Matched conditions: ALS
Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
ALS drug trial extended to test Long-Term benefits
Disease control TerminatedThis study aimed to see if continuing an oral medication called edaravone for up to 48 more weeks could help slow the progression of ALS (amyotrophic lateral sclerosis) in people who had already completed a previous trial. It involved 202 participants and compared two different d…
Matched conditions: ALS
Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Could video calls ease the burden of hospital visits for ALS patients?
Symptom relief TerminatedThis study aimed to see if people with ALS (Lou Gehrig's disease) who use a breathing machine at night would be more satisfied with follow-up care done from home via video call, compared to regular in-person hospital visits. It involved 38 patients living at home who were already…
Matched conditions: ALS
Phase: NA • Sponsor: AGIR à Dom • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC